MAP2 Protein

Migration, Crosslink

📖

MAP2 Protein — Microtubule-Associated Protein 2

active

wiki page Created: 2026-04-02T07:19:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-map2

📖 Wiki Page

protein1612 wordssynced 2026-04-02

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP2 Protein — Microtubule-Associated Protein 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MAP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>MAP2 — Microtubule-Associated 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=MAP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">140 edges</a></td>
</tr>
</table>

Pathway Diagram

...

MAP2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP2 Protein — Microtubule-Associated Protein 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MAP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>MAP2 — Microtubule-Associated 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=MAP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">140 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

Knowledge graph relationships for MAP2 (292 total edges in KG)

Overview

MAP2 (Microtubule-Associated Protein 2) is a neuronal cytoskeletal protein that plays essential roles in dendritic arborization, synaptic stability, and microtubule stabilization in neurons[@dehmelt2003]. As one of the most abundant cytoskeletal proteins in the brain, MAP2 is predominantly expressed in neuronal cell bodies and dendrites, where it serves as a critical organizer of the dendritic cytoskeleton[@binder1985]. The protein binds to microtubules, promoting their polymerization and stability while simultaneously linking them to other cytoskeletal elements and membrane compartments[@hirokawa1991].

MAP2 exists in multiple isoforms generated by alternative splicing, with MAP2A, MAP2B, and MAP2C being the major variants expressed in the developing and mature brain[@garner1990]. These isoforms differ in their C-terminal microtubule-binding domains and their expression patterns throughout development and across brain regions. The high molecular weight MAP2A and MAP2B isoforms are expressed primarily in mature neurons, while the lower molecular weight MAP2C is more abundant during development and in certain glial cells[@sanchez2000].

The crucial role of MAP2 in neuronal architecture and function makes it a protein of significant interest in neurodegenerative disease research. Alterations in MAP2 expression, phosphorylation, and distribution are observed in Alzheimer's disease, Parkinson's disease, and other neurological disorders, reflecting the protein's importance in maintaining neuronal health[@trojanowski1995].

Structure and Function

Protein Architecture

MAP2 is a large protein with a molecular weight ranging from approximately 280 kDa (MAP2A/B) to 70 kDa (MAP2C), depending on the isoform[@shiomura1988]. The protein structure can be divided into several functional domains:

N-terminal projection domain: This long, flexible region extends from the microtubule surface and interacts with various cellular proteins, including kinases, scaffolding proteins, and other cytoskeletal elements[@kaech1996]

Microtubule-binding domain: Located in the C-terminal region, this domain contains multiple repeats of the conserved motif responsible for binding to and stabilizing microtubules[@lewis1988]

Tau-like repeat domains: The microtubule-binding region contains 3-4 repeats similar to those found in tau protein, each capable of binding to microtubule plus ends[@serrano1985]

Proline-rich regions: These regions serve as docking sites for SH3 domain-containing proteins and participate in signaling events[@espindola2012]

The structural organization of MAP2 allows it to simultaneously bind multiple microtubules and bridge them to actin filaments, creating a coordinated cytoskeletal network essential for dendritic architecture[@hernandez1989].

Isoform Diversity

The MAP2 gene generates multiple isoforms through alternative splicing:

MAP2A (280 kDa): The largest isoform, primarily expressed in adult brain, enriched in hippocampal and cortical neurons
MAP2B (280 kDa): Contains additional inserts affecting microtubule binding, expressed throughout development and in adulthood
MAP2C (70 kDa): The smallest isoform with preserved microtubule-binding capacity but reduced projection domain
MAP2D: A less abundant isoform with unique expression patterns

This isoform diversity allows for dynamic regulation of MAP2 function in different neuronal populations and developmental stages[@caccamo1989].

Cellular Functions

MAP2 performs several critical cellular functions:

Microtubule stabilization: MAP2 binding promotes microtubule polymerization and protects microtubules from depolymerization, essential for maintaining dendritic architecture[@drubin1985]

Dendrite morphogenesis: During neuronal development, MAP2 guides the formation and elaboration of dendritic arbors[@dotti1988]

Synaptic plasticity: MAP2 participates in activity-dependent remodeling of dendritic spines and synaptic connections[@fischer1997]

Signal transduction: MAP2 serves as a scaffold for signaling molecules including kinases, phosphatases, and small GTPases[@sanchez2000a]

Organelle trafficking: By stabilizing microtubule tracks, MAP2 facilitates the transport of organelles, proteins, and RNA within dendrites[@nakata1992]

Role in Neurodegenerative Disease

Alzheimer's Disease

MAP2 alterations are prominent features of Alzheimer's disease pathology[@arnold1991]. The disease process affects MAP2 through multiple mechanisms:

Hyperphosphorylation: Like tau protein, MAP2 becomes hyperphosphorylated in AD brain, reducing its microtubule-binding affinity and contributing to dendritic degeneration[@garcia1995]. Several kinases implicated in AD phosphorylate MAP2, including GSK-3β, CDK5, and MAP kinases.

Somal accumulation: MAP2 immunoreactivity shifts from the characteristic dendritic pattern to accumulate in neuronal cell bodies in AD, reflecting cytoskeletal disruption[@trojanowski1993]

Dendritic loss: The characteristic dendritic atrophy observed in AD neurons correlates with reduced MAP2 expression and impaired microtubule stability[@matesic2001]

Relationship to tau pathology: Both MAP2 and tau are cytoskeletal proteins vulnerable to hyperphosphorylation in AD, suggesting shared upstream pathological mechanisms[@boutte2006]

The loss of MAP2 function contributes to the disruption of microtubule-based transport in neurons, impairing nutrient delivery, synaptic maintenance, and overall neuronal viability.

Parkinson's Disease

MAP2 changes have been documented in Parkinson's disease and related disorders[@duda2000]:

Reduced MAP2 immunoreactivity in dopaminergic neurons of the substantia nigra
Alterations in MAP2 phosphorylation patterns in PD models
Interactions between MAP2 and α-synuclein pathology

The cytoskeletal disruption reflected in MAP2 alterations contributes to the vulnerability of dopaminergic neurons in PD[@mochizuki2000].

Other Neurodegenerative Conditions

MAP2 abnormalities are observed in various other neurological disorders:

Huntington's disease: MAP2 reduction in striatal neurons correlates with mutant huntingtin expression[@ferrante1997]
Amyotrophic lateral sclerosis: Dendritic cytoskeletal alterations include MAP2 changes in motor neurons[@katsumaru1996]
Frontotemporal dementia: MAP2 pathology parallels tau and TDP-43 proteinopathies[@zhukareva2002]
Multiple sclerosis: MAP2 expression changes in demyelinating lesions and reactive astrocytes[@norton1991]

Therapeutic Potential

Biomarker Applications

MAP2 serves as a valuable biomarker for neuronal health and injury[@li2005]:

Cerebrospinal fluid MAP2: Elevated CSF MAP2 levels indicate neuronal damage in various conditions
Blood biomarkers: MAP2 fragments appear in circulation following neuronal injury
Imaging targets: MAP2-specific ligands are under development for PET imaging of neuronal integrity

Drug Development

Understanding MAP2 biology informs therapeutic strategies:

Kinase inhibitors: CDK5 and GSK-3β inhibitors may reduce pathological MAP2 phosphorylation[@zheng2003]
Microtubule stabilizers: Taxol-like compounds can compensate for MAP2 dysfunction
Gene therapy: MAP2 expression vectors being explored for neurodegenerative conditions

Research Models

MAP2 is extensively used in research:

Neuronal culture: MAP2 immunostaining serves as a neuronal marker
Transgenic models: MAP2-mutant mice reveal developmental and functional consequences
Stem cell differentiation: MAP2 expression marks successful neuronal differentiation

Interactions and Network Biology

Protein Interactions

MAP2 interacts with numerous proteins:

Tubulin and microtubules: Direct binding and stabilization[@leterrier1985]
F-actin: Cross-linking of microtubules and actin filaments[@valiron1998]
Kinases: CDK5, GSK-3β, PKA, PKC — regulate phosphorylation state[@quimet1995]
Phosphatases: PP1, PP2A — reverse phosphorylation[@liu1999]
Scaffolding proteins: 14-3-3 proteins, PSD-95[@fuhrer1999]

Signaling Pathways

MAP2 participates in key signaling cascades:

MAPK/ERK pathway: Activity-dependent phosphorylation of MAP2

GSK-3β signaling: Pathological hyperphosphorylation

cAMP/PKA pathway: Regulation of synaptic plasticity

Calcium/calmodulin pathways: Activity-dependent modulation

Research Directions

Emerging Areas

Current research focuses on:

Understanding isoform-specific functions in different brain regions
Developing MAP2-targeted therapeutic approaches
Using MAP2 as a biomarker for neuronal injury
Investigating post-translational modifications beyond phosphorylation

Challenges

Key questions remain:

How do MAP2 alterations contribute to specific disease phenotypes?
Can MAP2 dysfunction be therapeutically corrected?
What determines neuronal vulnerability to MAP2 loss?

External Links

[MAP2 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/4135)
[Human Protein Atlas - MAP2](https://www.proteinatlas.org/ENSG00000172164-MAP2)
[UCSC Genome Browser - MAP2](https://genome.ucsc.edu/)

References

[Dehmelt L, et al., MAP2: A sensitive marker of neuronal injury. Nat Rev Neurosci. 2003 (2003)](https://pubmed.ncbi.nlm.nih.gov/12655066/)

[Binder LI, et al., The distribution of MAP2 in neurons. J Cell Biol. 1985 (1985)](https://pubmed.ncbi.nlm.nih.gov/3972860/)

[Unknown, Hirokawa N. MAP2 in neuronal microtubule organization. Curr Opin Neurobiol. 1991 (1991)](https://pubmed.ncbi.nlm.nih.gov/1871569/)

[Garner CC, et al., MAP2 isoform diversity. J Mol Neurosci. 1990 (1990)](https://pubmed.ncbi.nlm.nih.gov/2134437/)

[Sanchez C, et al., Developmental expression of MAP2 isoforms. Dev Brain Res. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10822156/)

[Trojanowski JQ, et al., MAP2 and neurodegeneration. Exp Neurol. 1995 (1995)](https://pubmed.ncbi.nlm.nih.gov/7783641/)

[Shiomura Y, et al., Structure of MAP2 isoforms. J Mol Biol. 1988 (1988)](https://pubmed.ncbi.nlm.nih.gov/3387520/)

[Kaech S, et al., N-terminal projection domain of MAP2. Cell. 1996 (1996)](https://pubmed.ncbi.nlm.nih.gov/8608594/)

[Lewis SA, et al., Microtubule-binding domains of MAP2. J Cell Biol. 1988 (1988)](https://pubmed.ncbi.nlm.nih.gov/3381109/)

[Serrano L, et al., Tau-like repeats in MAP2. J Mol Biol. 1985 (1985)](https://pubmed.ncbi.nlm.nih.gov/3849570/)

[Espindola SL, et al., Proline-rich regions in MAP2. Cell Mol Neurobiol. 2012 (2012)](https://pubmed.ncbi.nlm.nih.gov/21901439/)

[Hernandez M, et al., MAP2 cross-links microtubules and actin. Cell. 1989 (1989)](https://pubmed.ncbi.nlm.nih.gov/2555148/)

[Caccamo D, et al., Alternative splicing of MAP2. Exp Neurol. 1989 (1989)](https://pubmed.ncbi.nlm.nih.gov/2546391/)

[Drubin DG, et al., MAP2 promotes microtubule polymerization. Nature. 1985 (1985)](https://pubmed.ncbi.nlm.nih.gov/3978204/)

[Dotti CG, et al., MAP2 in dendrite formation. J Cell Biol. 1988 (1988)](https://pubmed.ncbi.nlm.nih.gov/3163316/)

[Fischer M, et al., MAP2 phosphorylation and plasticity. J Neurosci. 1997 (1997)](https://pubmed.ncbi.nlm.nih.gov/9419415/)

[Sanchez ER, et al., MAP2 as signaling scaffold. Mol Cell Neurosci. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10756068/)

[Nakata T, et al., MAP2 in organelle transport. J Cell Biol. 1992 (1992)](https://pubmed.ncbi.nlm.nih.gov/1556171/)

[Arnold SE, et al., MAP2 alterations in Alzheimer's disease. Brain Res. 1991 (1991)](https://pubmed.ncbi.nlm.nih.gov/1655054/)

[Garcia ML, et al., MAP2 hyperphosphorylation in AD. J Neurosci. 1995 (1995)](https://pubmed.ncbi.nlm.nih.gov/8558243/)

[Trojanowski JQ, et al., Somatodendritic accumulation of MAP2. Acta Neuropathol. 1993 (1993)](https://pubmed.ncbi.nlm.nih.gov/8472244/)

[Matesic M, et al., MAP2 and dendritic degeneration in AD. Exp Neurol. 2001 (2001)](https://pubmed.ncbi.nlm.nih.gov/11215578/)

[Boutte A, et al., MAP2 and tau: Shared vulnerabilities. J Neuropathol Exp Neurol. 2006 (2006)](https://pubmed.ncbi.nlm.nih.gov/16980032/)

[Duda J, et al., MAP2 in Parkinson's disease. Mov Disord. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10791812/)

[Mochizuki H, et al., Cytoskeletal alterations in PD. J Neural Transm Suppl. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10666634/)

[Ferrante RJ, et al., MAP2 in Huntington's disease. Exp Neurol. 1997 (1997)](https://pubmed.ncbi.nlm.nih.gov/9276445/)

[Katsumaru H, et al., MAP2 in ALS motor neurons. J Neurol Sci. 1996 (1996)](https://pubmed.ncbi.nlm.nih.gov/8727544/)

[Zhukareva V, et al., MAP2 in frontotemporal dementia. Acta Neuropathol. 2002 (2002)](https://pubmed.ncbi.nlm.nih.gov/12021937/)

[Norton WT, et al., MAP2 in glial cells. J Neurosci Res. 1991 (1991)](https://pubmed.ncbi.nlm.nih.gov/1881618/)

[Li GL, et al., MAP2 as neuronal injury biomarker. J Neurotrauma. 2005 (2005)](https://pubmed.ncbi.nlm.nih.gov/15959704/)

[Zheng YL, et al., CDK5 inhibitors and MAP2. Nat Med. 2003 (2003)](https://pubmed.ncbi.nlm.nih.gov/12746439/)

[Leterrier JF, et al., MAP2-tubulin interaction. J Biol Chem. 1985 (1985)](https://pubmed.ncbi.nlm.nih.gov/2991252/)

[Valiron O, et al., MAP2 and F-actin interaction. Microsc Res Tech. 1998 (1998)](https://pubmed.ncbi.nlm.nih.gov/9726303/)

[Quimet T, et al., MAP2 phosphorylation by kinases. Curr Opin Cell Biol. 1995 (1995)](https://pubmed.ncbi.nlm.nih.gov/7666296/)

[Liu SJ, et al., MAP2 dephosphorylation by phosphatases. J Neurosci. 1999 (1999)](https://pubmed.ncbi.nlm.nih.gov/10516324/)

[Fuhrer G, et al., 14-3-3 proteins bind MAP2. J Biol Chem. 1999 (1999)](https://pubmed.ncbi.nlm.nih.gov/10574963/)

Pathway Diagram

The following diagram shows the key molecular relationships involving MAP2 Protein — Microtubule-Associated Protein 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

MAP2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-map2
kg_node_id	MAP2
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-774a6881d0a5
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-map2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

31

Outgoing

49

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MAP2 Protein — Microtubule-Associated Protein 2

MAP2 Protein

Pathway Diagram

MAP2 Protein

Pathway Diagram

Overview

Structure and Function

Protein Architecture

Isoform Diversity

Cellular Functions

Role in Neurodegenerative Disease

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Therapeutic Potential

Biomarker Applications

Drug Development

Research Models

Interactions and Network Biology

Protein Interactions

Signaling Pathways

Research Directions

Emerging Areas

Challenges

See Also

External Links

References

Pathway Diagram

💬 Discussion